Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

The dire need for Stroke therapies, now with a related cause being COVID, seems to suggest that the current COVID issues may actually provide patients for the UK - DMT microdose CTs. Maybe we can even look for expedited completion.

" In the EU, stroke is the leading cause of adult disability according to a 2020 study, and Covid has worsened the scenario. The number of patients with stroke requiring long term assistance and rehabilitation has dramatically increased since the outbreak of Covid-19, as well as flu-related strokes in young people. While some stroke survivors will recover, impairment of the upper limbs can become chronic and seriously affect the behaviour of the patient in up to 75% of stroke patients."

from another MB...GLTA...